(Q82540613)

English

High levels of IDO-expressing CD16+ peripheral cells, and Tregs in graft biopsies from kidney transplant recipients under belatacept treatment

scientific article published on 01 November 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094802%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

High levels of IDO-expressing CD16+ peripheral cells, and Tregs in graft biopsies from kidney transplant recipients under belatacept treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094802%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

J Furuzawa-Carballeda

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094802%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

G Lima

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094802%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

N Uribe-Uribe

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094802%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

C Avila-Casado

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094802%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

E Mancilla

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094802%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

L E Morales-Buenrostro

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094802%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

J Pérez-Garrido

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094802%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

M Pérez

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094802%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

G Cárdenas

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094802%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

L Llorente

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094802%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

J Alberú

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094802%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

1 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094802%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Transplantation Proceedings

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094802%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

42

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094802%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094802%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

3489-3496

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094802%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Inhibition of T cell proliferation by macrophage tryptophan catabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

Indoleamine 2,3-dioxygenase activity is increased in patients with systemic lupus erythematosus and predicts disease activation in the sunny season.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

IDO-expressing regulatory dendritic cells in cancer and chronic infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

Mechanisms dependent on tryptophan catabolism regulate immune responses in primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

Tryptophan catabolism and regulation of adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

IDO expression by dendritic cells: tolerance and tryptophan catabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

CTLA-4-Ig regulates tryptophan catabolism in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

Costimulation blockade with belatacept in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

Costimulation blockade--what will the future bring?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

Abatacept modulates human dendritic cell-stimulated T-cell proliferation and effector function independent of IDO induction

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

Modulation of tryptophan catabolism by regulatory T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

Indoleamine 2,3-dioxygenase in transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

The CD16(+) (FcgammaRIII(+)) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

CD16+ and CD16− human blood monocyte subsets differentiate in vitro to dendritic cells with different abilities to stimulate CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

Tryptophan catabolism generates autoimmune-preventive regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

Antigen-specific suppression by induced CD4+CD25high regulatory T cells in kidney recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

The roles of CD25+CD4+ regulatory T cells in operational tolerance after living donor liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

The role of Foxp3+ regulatory T cells in kidney transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

Messenger RNA for FOXP3 in the urine of renal-allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.037

7 January 2021

Identifiers

10.1016/J.TRANSPROCEED.2010.08.037

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094802%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21094802%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q82540613&oldid=2231851499"